Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences

PR NewswireNov 13 05:58

H.C. Wainwright Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Maintains Target Price $18

Futu NewsNov 8 20:35 · Ratings

Cantor Fitzgerald Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Maintains Target Price $13

Futu NewsNov 7 21:31 · Ratings

Vanda Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECNov 7 20:13 · Announcements

Express News | Vanda Pharmaceuticals Inc : Jefferies Cuts Target Price to $5.5 From $6

BreakingsNov 7 18:51

Vanda Pharmaceuticals Reports Strong Q3 2024 Growth

TipRanksNov 7 12:46